Constellation Pharma recruits its former BD chief to take the helm as CEO
Constellation Pharmaceuticals has lured back its former BD chief to take the helm.
Jigar Raythatha, the first executive recruited at a booming Jounce, is now moving up from his role as chief business officer to become the CEO at Cambridge, MA-based Constellation, where he also led the BD team for a 4-year stint.
Constellation has had its ups and downs. Former CEO Keith Dionne — who left in 2016 and is now an entrepreneur-in-residence growing up new companies at Third Rock — scrapped a buyout option deal with Genentech in 2015. The big Roche subsidiary had tried to cherry pick assets from the biotech’s epigenetics pipeline, Dionne told me at the time, rather than follow through with a buyout. And Dionne notably celebrated the breakup with a series of party Tweets.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.